chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the second dose of Moderna covid-19 vaccine) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 11-Jul-2020 and the estimated date of delivery was 17-Apr-2021. On 09-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the second dose of Moderna covid-19 vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirtieth week of the pregnancy.  On 09-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant patient received the second dose of Moderna covid-19 vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2020, Pregnancy test: positive (Positive) Positive.         No treatment information was provided.
redness at site of injection that spread to large portion of upper arm. symptoms improving 7 days post injection. pt reports using Benadryl spray.
9-26-19 Jaw swelling, left ear felt hot. Joint pain, knee swelled Lt. Rash all over her body.  9-30-19 Rash on lower extremities, worse on anterior right tigh, dark red in color.
Patient presented to health dept on 07/25/16 to receive immunizations. Hep A, Gardasil 9, and Bexsero administered. Patient calls in to health dept today, 08/08/16, c/o pain at injection site in right arm and generalized body aches. Patient denies c/o fever and denies c/o swelling or redness at injection site. She reports pain primarily at injection site at right arm and reports has been present since vaccination. Patient reports no ROM limitations. Called VFC on-call nurse, who advises pain at injection site can be common may take time to resolve. Also advises generalized body aches may or may not be related to vaccination. Patient called and reassured pain at injection site not uncommon and should resolve over time. Advised generalized body aches may or may not be related to vaccination. Advised to call our office back with any other questions or concerns or if would develop other sxs.  Patient voiced understanding.
all she had was a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (all she had was a sore arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Accident automobile (Patient says a lot of her previous pain from the accident had come back.). Concomitant products included ALPRAZOLAM (XANAX), HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN), MELATONIN and BOSWELLIA SACRA ESSENTIAL OIL (FRANKINCENSE) for an unknown indication.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (all she had was a sore arm). At the time of the report, MYALGIA (all she had was a sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that she has been taking elderberry and internal frankincense  or boswellia serrata to prevent COVID so far. No treatment details were reported.   This case was linked to MOD-2021-099096 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 12-Jun-2021: No new information was updated.
Headache, Myalgia,  heat waves Narrative:  Myalgia, headache, heat waves; took tylenol.
Rash on his leg; This is a spontaneous report from a contactable consumer or other non hcp (patient). A male patient of an unspecified age received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date at dose number unknown, single for covid-19 immunisation. Medical history included colitis ulcerative (He said he also takes entyvio for ulcerative colitis). Concomitant medication included vedolizumab (ENTYVIO) taken for colitis ulcerative, start and stop date were not reported. On an unspecified date the patient experienced rash on his leg. He is calling about the covid 19 vaccine. He had already reported and has a manufacturers report. He had called about a reaction, it was nothing major. It is about when it was taken. It says are there any other side effects other than the rash on his leg that he had before. He said he also takes entyvio for ulcerative colitis. He can't remember the actual side effect. There is a questionnaire. He was trying to think, he thinks it was in march. Someone else he knew had a horrible headache but it wasn't that for him. Reporter doesn't remember who it was he thinks it was a friend of a friend who had taken Moderna. No further details provided. He was calling to see if it would show what side effect he had reported. Outcome of the event was unknown.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow up attempts are completed. No further information is expected.
p/vax pt vomited; fainted for 2 min w/greenish color; taken to ER; pedialyte given; then disch p/4hr
This spontaneous report was received from a health professional (nurse) refers to a patient of unknown demographics. Patient's pertinent medical history and drug reactions/allergies were unspecified. On 08-JUN-2015 the patient was inadvertently administered with an expired dose of MMR II subcutaneous (lot # J006953, expiry date: 07-JUN-2015). Concomitant medications were not reported. No adverse effects were reported. Additional information has been requested.
Patient experienced blood in her urine the day after each dose of the vaccine. The first time she went to her health care provider who treated her for a UTI prophylactically and completed a urinalysis where it was identified she did not have an infection. The patient confirmed she was not have menstrual bleeding and her mense came between both vaccines. She has as hormonal (lilyetta) IUD and does occasionally have a menstrual cycle. She recieved a 7 day course of keflex and no treatment after the second vaccine
Immobility and extreme jiont and muscle pain from shoulder and progressing down to fingertips.  Rested arm, treated with ice, heat, took regular Tylenol.  On third day provided prescribed Gabapentin  100 mg, one or two tablets 3x per day.  And Diclofenac Sodium Topical,Gel 1%  4 times per day.  One week out from the vaccination, movement of arm id recovering but stimmnot full movement in shoulder joint, and some muscle soreness remains.
very sick; 2nd dose it is putside of the 42 day  window; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of COVID-19 (very sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose it is putside of the 42 day  window) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced COVID-19 (very sick). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose it is putside of the 42 day  window). At the time of the report, COVID-19 (very sick) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose it is putside of the 42 day  window) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   As a treatment for the SARS-CoV-2 test positive patient was intubated during his hospitalized time. No concomitant medication was reported.  This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273, unknown Lot # with no associated AEs and the event of positive SARS-COV-2 infection is assessed as not applicable.; Sender's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273, unknown Lot # with no associated AEs and the event of positive SARS-COV-2 infection is assessed as not applicable.
From the first vaccine I felt chills, bone pain, sore throat, fever. From the second I felt little chills, finger numbness, shortness of breath, fast heart
Patient stated she had an allergic reaction to a flu shot 4 years prior. I agreed to the Covid shot but asked her to wait 30-45 minutes in pharmacy waiting room for observation. She agreed but no more than 10 minutes after the shot she said she felt strange. I gave her a 25mg diphenhydramine but her voice became hoarse so I gave her an epinephrine injection. I told her we should call an ambulance but she refused and said she would not go in an ambulance "again". I said okay but if symptoms returned and I had to give a second shot I would call EMS. She agreed. She seemed better and her breathing and swallowing were OK and her hoarseness went away. We then called her primary physician and she left for her office. The
Vertigo - positional; dizziness; nausea; his is a spontaneous report received from a contactable consumer, the patient. A 42-year-old-male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248), via an unspecified route of administration in left arm on 25Mar2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history of the patient included hypertension. The concomitant medications included lisinopril (MANUFACTURER UNKNOWN) 20mg daily. The patient previously received the first dose of (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in left arm on 02Mar2021(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 25Apr2021, the patient experienced vertigo -positional, dizziness and nausea. The treatment received for the events included meclizine 25mg three times per day. The clinical outcome of the events vertigo positional, dizziness and nausea was not recovered at the time of reporting.   Information about lot/batch number cannot be obtained. No further information is expected.
Child was at table, fell limp in mother's arms who caught his fall. He was moved to ground. Has swollen area to left side of head. Skin intact. HR=98, BP= 100/50
Patient complied about pain headache or migraine  .Onsite EMS was called vitals BP 150/98 BG 103    100% O2 room air HR 86. Patient Refused Evaluation/Care, Left aginst medical advice.
When I got covid I had a really painful sore throat, and I had a headache. On day 2 my whole body hurt especially my legs. I felt fatigued and foggy. On day 3 or 4 I was congested with a runny nose. On day 6 I started feeling better. I was coughing a little bit. I went to the doctor on May 20 2022. I was prescribed penicillin on the assumption that I had strep,  but I don't have it so I haven't took that medication. Since I found out that I had covid my chest has been feeling a little funny.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 51-year-old male patient received BNT162b2 (BNT162B2), in Jan2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 50 years, in right arm for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history included: "High cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19 which included Paxlovid from 28Sep2022 to 03Oct2022. Additional information: BNT162b2 was administered at 05:00 PM.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt called on 1/23, rash on arm 4 inches in diameter, tender warm to touch. Pink with slight swelling. Had not tried anything yet. Instructed patient to apply ice pack or cool rag. Take APAP or ibuprofen and BENADRYL. Draw a circle around rash to see if it gets bigger/smaller/spreads, etc. Pt stopped in on 1/25. Rash was going away.
Information has been received from a registered nurse through the Merck pregnancy registry concerning a 38 year old female patient with no concurrent conditions who on 12-NOV-2002, was vaccinated with a dose of varicella virus vaccine live.  Concomitant therapy included a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation)(MSD) and tuberculin  purified protein derivatives (TB). The patient was "pregnant at the time of vaccination" and as of 11-MAR-2003, the patient was at least 4 months pregnant. The reporter noted that the patient had not received any pre-natal care, so her exact due date was unknown. Unspecified medical attention was sought. Follow up information was received from a registered nurse. The reporter indicated that the patient had nine previous pregnancies including a 7 full term births and 1 pre term birth at 28 gestational weeks. There was no still birth , miscarriage or birth defect in any previous pregnancy. The patient's last menstrual period was approximately 14-NOV-2002 and her estimated due date was 21-AUG-2003. The patient was administered varicella virus vaccine live for immigration purposes. The patient was an Albanian refugee. It was unknown if the patient was tested for varicella antibodies before vaccination with varicella virus vaccine live. It was unknown if the patient developed a local reaction at the vaccination site. It was unknown if the patient developed varicella or herpes zoster symptoms post vaccination. On 17-APR-2003 at 22 weeks gestation, an ultrasound revealed normal findings including BPD 5.4 cm and placenta anterior. Complications during pregnancy included gestational diabetes The gestational diabetes was treated with daily insulin 75/25 form 18/JUN/2003 to 11/Aug/2003 (18-JUN-2003 to 20/JUN/2003: 10 units BID; 20-JUN-2003 to 11-AUG-2003: 15/10 units). Infections during pregnancy included a left molar abscess. The left molar abscess was treated with "PEN U-K" 500 mg four times a day for seven days from 30-JUN-2003 to 07-JUL-2003 (28 doses taken). Starting in mid July 2003, bi weekly non stress tests were within normal limits. On 05-AUG-2003, a non-stress test was normal. On 11-AUG-2003, at 38 weeks and 5 days gestation, the patient gave birth a normal 8 pound , 0.5 ounce female infant. There were no complications during labor or delivery. There were no congenital anomalies, complications or abnormalities. There were no features of congenital varicella zoster syndrome.
About 25 pt recvd the 1st & 2nd doses of Engerix-B; upon receiving the 3rd dose in JUL & AUG91, several pts c/o pain @ inject site w/duration of only a few minutes;
While receiving Hospice care, tested positive for COVID illness, prior fully vaccinated status noted. Remained at baseline w/overall status during covid illness, asymptomatic for covid illness. Following completion of covid illness recovery, continued to decline as observed during extended hospice care. End of life progressed with overall decline  and she expired 6/8/21 at facility.
Vaccine expired 8/31/2022. Unknowingly gave vaccine 9/1/2022. No reaction reported.
Approximately 1 hr. after vaccines child's face became red, started itching, and had 2 episodes of emesis. Seen in office approximately 1 hr. later, redness improved. No additional episodes of emesis. Noted to have erythema on face and pink with wheals on abd. Given 120 mg BENADRYL PO.
Customer came to pharmacy at  2:50 pm on 3/23/18 and showed me an itching red and swollen left arm. She stated it was from a vaccination on 3/17/18. She stated the arm starting swelling on Monday 3/19/18. She was given equate brand diphenhydramine 2% and zinc 0.1% cream. She stated she would go see a doctor.
Began with scratchy throat that got increasingly worse as day went on.  Hacky cough began night of 1/20.  Felt like significant cold symptoms by next morning 1/21: runny nose, cough, fever up 99.4 (baseline is 97.2).
This spontaneous report was received from a 26 years old, female licensed practical nurse reporting on herself with no pertinent medica; history or drug reactions or allergies. The nurse noted that on 12-APR-2013 while preparing a dose of (Merck) PROQUAD (lot number and expiration date not reported) for a patient, she inadvertently "stuck" herself on her finger with a needle that contained the (merck) PROQUAD. Starting on 13-APR-2013 she noted "her finger was swollen and that the skin on her finger was tight". The nurse's present status was not recovered. The nurse stated that no treatment was given for the events. The nurse reported that none lab diagnostic studies were performed. The reported did not seek medical attention. Additional information has been requested.
A bad red rash larger than a quarter at injection site.; A bad red rash larger than a quarter at injection site.; This is a spontaneous report from a contactable other hcp. A 46-years-old non-pregnant female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EL9262) via intramuscular route administered on Arm Left on 22Jan2021 10:15 AM (Age at vaccination: 46 Years) as SINGLE DOSE for covid-19 immunisation at hospital. Medical history included hypertension. The patient had allergies to Aleve, Robaxin, Flexeril and Tramadol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The Concomitant medications included received within 2 weeks of vaccination included losartan (LOSARTAN) taken for an unspecified indication, start and stop date were not reported.  Patient did not receive other vaccine within four weeks of vaccination. The event had not resulted in death, life-threatening, prolonged hospitalisation, disabling/incapacitating or Congenital anomaly/birth defect. The patient did not receive treatment for adverse event. On 22Jan2021 the patient experienced A bad red rash larger than a quarter at injection site.  The outcome of the events was not recovered.  Follow-Up (15-Apr-2021): Follow-up attempts are completed. No further information is expected.
one out of seven people he checked on that had a death.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "one out of seven people he checked on that had a death.". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  Clinical course was reported that the 67-year-old caller refers that after the two initial doses of Pfizer BioNTech COVID-19 vaccine she has experienced extreme fatigue, brain fog, dizziness but not vertigo and difficulty processing information orally. Caller provides her Dr address to. Caller states: "That's part of it. I´m just not functional. There´s been some improvement but not enough for me to function normally. it´s a known side effect there´s an online community, about a year ago there were about 10 thousand people worldwide, it´s affected not only Pfizer but Moderna, Johnson & Johnson and Astra Zeneca. I don´t feel well. I feel dizzy all the time. I need to be able to function. I need to be able to see. I need to be able to feel like a can drive safely. The two lots that were given to me have some of the highest adverse responses submitted to VAERS to the CDC. If you have further information in regard to the lot numbers EN6198 EN6201. The brain fog is absolutely a side effect of the vaccine, because I´ve talked to other people whose had it. I had the vaccine and 5 hours later it happens. Because of my allergy I hadn't seen anyone in the preceding 10 days so it couldn't be that I got COVID. I tested negative. I haven't had COVID. this was caused by the vaccine. I have an allergy to alcohol fumes. With all people using sanitizer I could not go to hospitals or even go shopping for over a year. I was basically self-quarantining. There was a disparity between batches because once my nephew found what was going on with those two batches, he checked for everyone's else in the family most of them had negligible adverse reactions like people complaining about aches and stuff but there were there was one out of seven people he checked on that had a death. My batches (EN6198 EN6201) have 3 or 4 hundred deaths between them. "  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: one out of seven people he checked on that had a death.
Fever 102.7 48 hrs after administration cellulitis left anterior thigh.  3-4 cm annular area erythema and warmth.  Tenderness to touch.
Left arm swelling, hot, itchy, painful to touch, raised circular rash 3? diameter for 2.5 weeks after. 100° raised fever for one week. Weakness all over 2 weeks. 2 weeks of extreme fatigue. All over malaise, body aches, and weakness for 2 weeks after.  Anorexia for 2 weeks after.
Inadvertently gave a 3rd dose of Shingrix. Our charting software apparently did not send the 2nd dose of Shingrix to the state registry where I had referred to his previous vaccine record. Upon charting his bill for today's vaccines, I saw the 2nd dose of Shingrix had been givine in June of 20222 which did not show  on the state registry where I had reviewed his record.